• Home
  • Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.

Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.

Author List
Jacob S, Johnson M, Roque B, Quintal L, Rugo HS, Melisko M, Chien AJ
Publication
Clinical breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/413341184
Publication Year
2023
PubMed ID
37474374
Publication Title
Jacob S, Johnson M, Roque B, Quintal L, Rugo HS, Melisko M, Chien AJ. Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer. Clin Breast Cancer. 2023 10; 23(7):721-728.